What Intrinsyx Research Corporation does

Intrinsyx Research Corporation, doing business as Intrinsyx Bio, is a California-based agricultural biotechnology company that develops and commercializes proprietary endophyte-based biological products for global agriculture. The company's core technology rests on naturally occurring nitrogen-fixing and phosphorus-mobilizing endophyte microbes originally isolated by Dr. Sharon Doty at the University of Washington from poplar and willow trees in harsh Pacific Northwest environments, licensed exclusively to Intrinsyx Bio. Products combine synergistic endophyte strains delivered via seed treatment, foliar, in-furrow, and granular formulations in freeze-dried, liquid, and powder forms, and include own-brand offerings (Juno foliar/in-furrow; Rosetta Seed Treatment) as well as partner-distributed formulations (NUELLO iN via Syngenta; Tiros via Unium Bioscience) targeting broad-acre and specialty crops.

The company monetizes through a hybrid revenue model: (1) B2B wholesale product sales and licensing royalties to multinational agricultural partners (Syngenta globally, Unium Bioscience in the UK/NW Europe, SABIC for agri-nutrients), (2) direct-to-grower sales of own-branded products, and (3) licensing of foundational IP from the University of Washington. Its go-to-market is overwhelmingly channel-partner-led: Syngenta and Unium commercialize formulations under their own brands leveraging their global R&D and distribution capabilities, while Intrinsyx Bio supplies the proprietary microbial strains and fermentation know-how. Effective May 7, 2025, Syngenta acquired Intrinsyx Bio in full, integrating the company's nutrient use efficiency (NUE) portfolio into Syngenta's biologicals business unit; the standalone entity now operates as a wholly-owned subsidiary within Syngenta Group (owned by ChemChina/Sinochem).

Name

Intrinsyx Research Corporation

Legal name

Intrinsyx Biology Corp

Website

https://intrinsyxbio.com

Company type

Private

Founded year

2016

Operating status

Acquired

Headcount range

11–50 employees

Short description

Intrinsyx Bio is an agricultural biotechnology company that develops and licenses proprietary endophyte-based biological products that fix atmospheric nitrogen and mobilize soil phosphorus, commercialized globally through channel partnerships with Syngenta and Unium Bioscience, and acquired by Syngenta in May 2025.

Ownership category

akta.pro rank

Product category

Agricultural Biological Products

NAICS

Pesticide, Fertilizer, and Other Agricultural Chemical Manufacturing (3253)

SIC

Agricultural Chemicals (2870)

akta.pro primary industry

Biofertilizers & Microbial Inoculants (IMAEAEAG)

Keywords

• Microbial biological products
• Endophyte seed treatment
• Nitrogen fixing microbes
• Agricultural biological inputs
• Phosphorus mobilization products

Headquarters

HQ city

Moffett Field

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. B2B Product Sales through Channel Partners: Revenue generated through wholesale product sales to multinational agricultural partners (Syngenta globally, Unium Bioscience in UK) who commercialize and distribute endophyte products under their own brand names (e.g., NUELLO iN, Tiros) to farmers. One-time and ongoing license/distribution agreements.
2. Technology Licensing & Collaboration Agreements: Revenue from exclusive technology collaboration agreements with agricultural input companies (e.g., SABIC for agri-nutrients, Syngenta for biologicals). Intrinsyx Bio licenses proprietary endophyte technology for partner-led commercialization in defined markets.
3. Exclusive License of UW Research IP: Intrinsyx Bio holds an exclusive license from the University of Washington to commercialize the naturally occurring endophytes discovered by Dr. Sharon Doty, built on three decades of academic research in the plant microbiome.
4. Direct Product Sales (own brand): Direct-to-grower sales of own-branded products (Juno foliar, Rosetta ST seed treatment) via own storefront and website contact, with product formulations sold in 1.8-2.5 gallon liquid pack sizes.

Pricing tiers

Go-to-market motion3 records

Core offering

Intrinsyx Bio develops and commercializes proprietary endophyte-based biological products that combine synergistic microbial strains to fix atmospheric nitrogen and mobilize insoluble soil phosphorus. Its products (Juno foliar/in-furrow and Rosetta ST seed treatment) are delivered via seed treatment, foliar, in-furrow, and granular formulations for more than 20 crops. The company also licenses its patented endophyte technology to multinational agricultural partners such as Syngenta and Unium Bioscience for co-developed products like NUELLO iN.

Product overview

Intrinsyx Bio (Intrinsyx Research Corporation) offers a portfolio of naturally occurring endophyte-based agricultural biological products rather than a single unified software platform. The product portfolio includes Juno (a foliar and in-furrow endophyte application for broad-acre and specialty crops), Rosetta Seed Treatment (ST) (a seed-applied endophyte formulation for corn, small grains, soy, and canola), and partner-distributed offerings including NUELLO iN (the Syngenta-distributed biological seed treatment based on Intrinsyx's endophytes) and Tiros (the Unium Bioscience-distributed inoculant seed treatment first launched in the UK). All products share a common technological foundation: synergistic combinations of endophytes that fix atmospheric nitrogen and mobilize insoluble phosphorus, with formulations offered in liquid, freeze-dried, powder, and granular forms. Following Syngenta's May 2025 acquisition of Intrinsyx Bio, the company now operates as part of Syngenta's biologicals business unit with full global reach.

Differentiator

Problem solved

Functional benefit

Brands

• Juno: Endophyte-based product combining nitrogen-fixing and phosphorus-mobilizing microbes for foliar and in-furrow application across multiple crops (corn, wheat, soybeans, potatoes, cotton, canola, tomatoes, peppers, strawberries).
• Rosetta Seed Treatment (ST)

Products and services

• Juno Juno is an endophyte-based agricultural biological product that combines two synergistic endophytes to fix atmospheric nitrogen and mobilize insoluble soil phosphorus. It is designed for foliar and in-furrow application across crops including corn, wheat, potatoes, soybeans, canola, cotton, tomatoes, peppers, and strawberries, with recommended rates of 12-16 fl oz/acre and a 2.5-gallon liquid pack size.
• Rosetta Seed Treatment (ST) Rosetta ST is a seed treatment product combining two synergistic endophytes that fix nitrogen and increase phosphorus mobilization. It is compatible with current chemical and nutrient seed treatments and is targeted for corn, wheat, soy, and canola, with application rates of 0.75-15 fl oz per 100 lbs of seed depending on the crop, in a 1.8-gallon liquid formulation.
• NUELLO iN NUELLO iN is a biological seed treatment co-developed through the Syngenta-Intrinsyx Bio collaboration based on Intrinsyx Bio's proprietary endophyte formulations. It combines bacterial strains produced by Intrinsyx Bio with Unium's prebiotic stimulant to improve nutrient use efficiency, increase crop yield, and promote plant and soil health. Commercialized in the US, UK, Benelux, and Iberia.
• Tiros Tiros is an inoculant seed treatment based on Intrinsyx Bio's endophyte formulation, released and distributed by Unium Bioscience. It is available in the United Kingdom as a liquid to apply as a seed coat, with powder and small pellet forms being developed for in-field application during sowing.

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Recent moves8 records

Expansion highlights6 records

Emerging players

• Ginkgo Bioworks: Ginkgo Bioworks' agricultural biologicals program (including the former Joyn Bio joint venture with Bayer) develops engineered microbial solutions for nitrogen fixation, overlapping with Intrinsyx Bio's endophyte strategy.
• BioConsortia: BioConsortia develops microbial consortia for nitrogen fixation and phosphorus solubilization with a discovery platform similar in spirit to Intrinsyx Bio's endophyte collection.
• Plant Response: Plant Response develops biological products including endophyte- and microbe-based nutrient-use-efficiency and biocontrol solutions, positioning it as an emerging peer in the same biological-input category as Intrinsyx Bio.
• AgBiome: AgBiome uses a microbial discovery platform (GENESIS) to develop agricultural biologicals, including biological nitrogen-fixing and plant-health products comparable to Intrinsyx Bio's pipeline.

Broad incumbents

• Bayer Crop Science: Bayer offers biologicals within its Crop Science division (including Joyn Bio legacy and BioAct) and competes broadly in seed treatments and nutrient-use-efficiency inputs with Intrinsyx's portfolio.
• Novonesis (formerly Novozymes): Novonesis is the largest pure-play microbial solutions provider globally, supplying biocontrol and biofertility products across agriculture; it overlaps with Intrinsyx Bio's biological-input portfolio at scale.
• BASF Agricultural Solutions: BASF's agricultural biologicals portfolio (including inoculants and biostimulants) competes with Intrinsyx Bio's microbial offerings in row and specialty crops globally.

Direct peers

• Pivot Bio: Pivot Bio develops microbial nitrogen-fixing products for corn and other row crops (e.g., ProveN, ReturN), directly competing with Intrinsyx Bio's endophyte-based nitrogen fixation platform in nutrient use efficiency.
• Indigo Agriculture: Indigo Ag markets microbial seed treatments and foliar biologicals (e.g., Indigo N, Indigo P) that improve nutrient use efficiency, making it a directly comparable biological-input peer.
• Sound Agriculture: Sound Agriculture's Source product combines nitrogen fixation and phosphorus solubilization via microbial technology, closely mirroring Intrinsyx Bio's dual N+P endophyte value proposition in row crops.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/intrinsyx-bio

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Intrinsyx Research Corporation